Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroectodermal Tumor, Primitive”

1,063 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,063 results

Not applicableEnded earlyNCT04753658
What this trial is testing

Real World Data Collection Pediatric Neuroblastoma Treated With Lorlatinib

Who this might be right for
Neuroblastoma
Pfizer 15
Early research (Phase 1)Study completedNCT00005835
What this trial is testing

N99-02: Melphalan and Buthionine Sulfoximine

Who this might be right for
Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium 31
Testing effectiveness (Phase 2)UnknownNCT00180947
What this trial is testing

Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse

Who this might be right for
RhabdomyosarcomasNeoplasms, Connective and Soft TissueEwing Tumor+3 more
Gustave Roussy, Cancer Campus, Grand Paris 210
Early research (Phase 1)Study completedNCT01975116
What this trial is testing

P28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors

Who this might be right for
Teratoid Tumor, AtypicalChoroid Plexus NeoplasmsAnaplastic Astrocytoma+7 more
Pediatric Brain Tumor Consortium 18
Testing effectiveness (Phase 2)Ended earlyNCT00969722
What this trial is testing

MAb-3F8 Plus Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus 13-cis-Retinoic Acid (RA) Plus GM-CSF in Primary Refractory Neuroblastoma Patients

Who this might be right for
Primary Refractory Neuroblastoma
United Therapeutics 1
Not applicableLooking for participantsNCT04474964
What this trial is testing

Focal Radiotherapy Plus Low Dose Craniospinal Irradiation Followed by Adjuvant Chemotherapy in WNT Medulloblastoma.

Who this might be right for
Medulloblastoma, WNT-activated
Tata Memorial Centre 30
Testing effectiveness (Phase 2)Study completedNCT01326104
What this trial is testing

Vaccine Immunotherapy for Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor

Who this might be right for
MedulloblastomaNeuroectodermal Tumor
University of Florida 26
Early research (Phase 1)Looking for participantsNCT07172958
What this trial is testing

Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)

Who this might be right for
RhabdomyosarcomaEwing SarcomaNeuroblastoma+1 more
Children's National Research Institute 18
Testing effectiveness (Phase 2)Looking for participantsNCT05278208
What this trial is testing

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

Who this might be right for
High Grade GliomaMeningiomaEmbryonal Tumor+10 more
Nationwide Children's Hospital 65
Not applicableEnded earlyNCT01077440
What this trial is testing

Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant

Who this might be right for
Cancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more
Vanderbilt University 24
Early research (Phase 1)Study completedNCT02765243
What this trial is testing

Anti-GD2 4th Generation CART Cells Targeting Refractory and/or Recurrent Neuroblastoma

Who this might be right for
NeuroblastomaEffects of Immunotherapy
Zhujiang Hospital 12
Testing effectiveness (Phase 2)Looking for participantsNCT05642455
What this trial is testing

SPEARHEAD-3 Pediatric Study

Who this might be right for
Synovial SarcomaMalignant Peripheral Nerve Sheath Tumor (MPNST)Neuroblastoma (NBL)+1 more
USWM CT, LLC 20
Testing effectiveness (Phase 2)Study completedNCT00135135
What this trial is testing

Therapy for Children With Neuroblastoma

Who this might be right for
Neuroblastoma
St. Jude Children's Research Hospital 23
Early research (Phase 1)WithdrawnNCT01697514
What this trial is testing

LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma

Who this might be right for
Medulloblastoma, ChildhoodRhabdomyosarcoma
Eli Lilly and Company
Early research (Phase 1)Study completedNCT00036959
What this trial is testing

ABT-751 in Treating Young Patients With Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more
National Institutes of Health Clinical Center (CC) 90
Testing effectiveness (Phase 2)Study completedNCT00004078
What this trial is testing

Irinotecan in Treating Children With Refractory Solid Tumors

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus TumorChildhood Craniopharyngioma+18 more
Children's Oncology Group 181
Testing effectiveness (Phase 2)UnknownNCT00392340
What this trial is testing

Topotecan, Vincristine, and Doxorubicin in Treating Young Patients With Refractory Stage 4 Neuroblastoma

Who this might be right for
Neuroblastoma
Children's Cancer and Leukaemia Group 63
Testing effectiveness (Phase 2)UnknownNCT02771743
What this trial is testing

Response-based Treatment of High-risk Neuroblastoma

Who this might be right for
Newly Diagnosed High Risk Neuroblastoma
Samsung Medical Center 54
Not applicableStudy completedNCT04474678
What this trial is testing

Quality Improvement Project - "My Logbook! - I Know my Way Around!"; ("Mein Logbuch - Ich Kenne Mich Aus!")

Who this might be right for
Brain TumorNeurofibromatosesSarcoma+3 more
Medical University of Vienna 240
Testing effectiveness (Phase 2)Ended earlyNCT01628913
What this trial is testing

Efficacy and Safety of BEZ235 Compared to Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors

Who this might be right for
Pancreatic Neuroendocrine Tumors (pNET)
Novartis Pharmaceuticals 62
Load More Results